Towards Advanced iPSC-based Drug Development for Neurodegenerative Disease

被引：34
|
作者：
Pasteuning-Vuhman, Svetlana [1 ]
de Jongh, Rianne [1 ]
Timmers, Annabel [1 ]
Pasterkamp, R. Jeroen [1 ]
机构：
[1] Univ Utrecht, Univ Med Ctr, Dept Translat Neurosci, Utrecht Brain Ctr, Utrecht, Netherlands
来源：
TRENDS IN MOLECULAR MEDICINE | 2021年 / 27卷 / 03期
关键词：
FAMILIAL ALZHEIMERS-DISEASE; BLOOD-BRAIN-BARRIER; 3-DIMENSIONAL CELL-CULTURE; STEAROYL-COA DESATURASE; MOTOR-NEURONS; STEM-CELLS; MODEL; ALS; REVEALS; INHIBITION;
D O I：
10.1016/j.molmed.2020.09.013
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Neurodegenerative diseases (NDDs) are a heterogeneous group of diseases that are characterized by the progressive loss of neurons leading to motor, sensory, and/or cognitive defects. Currently, NDDs are not curable and treatment focuses on alleviating symptoms and halting disease progression. Phenotypic heterogeneity between individual NDD patients, lack of robust biomarkers, the limited translational potential of experimental models, and other factors have hampered drug development for the treatment of NDDs. This review summarizes and discusses the use of induced pluripotent stem cell (iPSC) approaches for improving drug discovery and testing. It highlights challenges associated with iPSC model ing and also discusses innovative approaches such as brain organoids and microfluidic-based technology which will improve drug development for NDDs.
引用
收藏
页码：263 / 279
页数：17
相关论文
共 50 条
  • [21] Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
    Mathur, Anurag
    Loskill, Peter
    Shao, Kaifeng
    Huebsch, Nathaniel
    Hong, SoonGweon
    Marcus, Sivan G.
    Marks, Natalie
    Mandegar, Mohammad
    Conklin, Bruce R.
    Lee, Luke P.
    Healy, Kevin E.
    SCIENTIFIC REPORTS, 2015, 5
  • [22] iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development
    Faravelli, Irene
    Frattini, Emanuele
    Ramirez, Agnese
    Stuppia, Giulia
    Nizzardo, Monica
    Corti, Stefania
    JOURNAL OF CLINICAL MEDICINE, 2014, 3 (04): : 1124 - 1145
  • [23] Recent Advances in High-Content Imaging and Analysis in iPSC-Based Modelling of Neurodegenerative Diseases
    Menduti, Giovanna
    Boido, Marina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [24] Immunotherapy: iPSC-based cancer vaccine
    Crunkhorn S.
    Nature Reviews Drug Discovery, 2018, 17 (4) : 242 - 242
  • [25] Promise and challenges of human iPSC-based hematologic disease modeling and treatment
    Ye, Zhaohui
    Chou, Bin-Kuan
    Cheng, Linzhao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (06) : 601 - 609
  • [26] Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy
    Sun, Congshan
    Serra, Carlo
    Kalicharan, Brianna Harley
    Harding, Jeffrey
    Rao, Mahendra
    CELLS, 2024, 13 (07)
  • [27] Power and optimal study design in iPSC-based brain disease modelling
    Brunner, Jessie W.
    Lammertse, Hanna C. A.
    van Berkel, Annemiek A.
    Koopmans, Frank
    Li, Ka Wan
    Smit, August B.
    Toonen, Ruud F.
    Verhage, Matthijs
    van der Sluis, Sophie
    MOLECULAR PSYCHIATRY, 2023, 28 (04) : 1545 - 1556
  • [28] Promise and challenges of human iPSC-based hematologic disease modeling and treatment
    Zhaohui Ye
    Bin-Kuan Chou
    Linzhao Cheng
    International Journal of Hematology, 2012, 95 : 601 - 609
  • [29] Development of a preclinical monkey model for iPSC-based T cell immunotherapy
    Iriguchi, Shoichi
    Miyake, Yasuyuki
    Miura, Tomoyuki
    Tachikawa, Ai
    Ueda, Tatsuki
    Taya, Kahoru
    Imai, Eri
    Ishii, Hiroshi
    Onoe, Hirotaka
    Matano, Tetsuro
    Kaneko, Shin
    CANCER SCIENCE, 2018, 109 : 102 - 102
  • [30] DEVELOPMENT OF IPSC-BASED γδT-CELL IMMUNOTHERAPY FOR DIGESTIVE CANCER
    Watanabe, Daisuke
    Azuma, Takeshi
    Aoi, Takashi
    GASTROENTEROLOGY, 2017, 152 (05) : S641 - S641
12345